© All rights reserved to Barnea Jaffa Lande Law offices

Search by Practice

Latest Updates /  Corporate

June 18, 2019

Barnea Represented Axcel in the Acquisition of Phase One

Our firm represented Axcel in the acquisition of Phase One from Silverfleet Capital. Axcel is a leading Nordic private equity firm focusing on mid-market companies. It has a broad base of both Nordic and international investors.

June 11, 2019

The Annual Conference of the Association of Corporate Counsel in Israel

Dr. Zvi Gabbay led a panel on the subject of the legal advisor as a legal crisis facilitator at the annual conference of the Association of Corporate Counsel in Israel. Present at the conference were outgoing Justice Minister Ayelet Shaked and other senior legal officials.

May 6, 2019

Redomiciling an Israeli Public Company to Delaware

On April 12, 2019, Arcturus Therapeutics Ltd., an Israeli public company traded on NASDAQ, published in the United States a prospectus and proxy statement (convening a general meeting of shareholders of the company). Publishing the prospectus is an advanced step toward completing an arrangement between the company and its shareholders.

April 28, 2019

Negotiation Workshop for Modi'in City Council Members

Dr. Zvi Gabbay conducted a negotiation workshop today for members of the Modi'in City Council, as part of the Open University's directors' course.

April 3, 2019

Event: The Role of Boards of Directors in Maintaining Honesty

Our firm hosted today the Israel's Directors Union for a seminar on the prevention of bribery and corruption. Dr. Zvi Gabbay lectured on the duties of boards of directors in Israel, and Adv. Hadar Israeli presented the American perspective.

March 21, 2019

Crowdfunding – The New World of Investments in Israel and in the United States

The crowdfunding model enables the general public investment opportunities that were previously reserved only for sophisticated or institutional investors. In this article we examine the Israeli and American models and why the Israeli legislators should find ways to make the crowdfunding channel more attractive, for both investors and companies seeking funding.

March 20, 2019

Barnea Represented Danel Ltd. in the Acquisition of Levinger Group

Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.

March 13, 2019

Eight Basic Terms Relating to Antitrust and Competition

When reaching business decisions, nearly every manager must consider issues relating to restrictive trade practices. Click to read basic terms that every business should know about the antitrust law.

January 2, 2019

Liability of Officers and Functionaries in an Insolvent Corporation

Chapter 8 of the new Insolvency and Economic Rehabilitation Law addresses the liability of officers and functionaries. The law’s main innovation is that - beyond liabilities toward the corporation, which already existed prior to the enactment of the law, such as fiduciary duty and duty of care - special liability will also be imposed on the corporation’s officers and functionaries.

December 24, 2018

Calcalist Article on the Breakdown of Control in Companies

Adv. Micky Barnea was interviewed for an article in Calcalist's Executive Magazine about the superseding power of CEOs over the board of directors in public companies.

December 20, 2018

Update to Block Exemptions for Joint Ventures and Restraints Ancillary to Mergers

Two important block exemptions have been updated recently: the exemption for joint ventures and the exemption for restraints ancillary to mergers. The amendments transfer the examination of the intensity of the harm to competition deriving from these arrangements from the Israel Antitrust Authority to the business sector.

December 18, 2018

Tax Aspects of Business Restructuring - New Tax Circular

Recently, the Israel Tax Authority published a circular discussing business restructuring in multinational groups.

December 13, 2018

Companies Required to Amend Option Plans

A new circular by the Israel Tax Authority determines the terms for granting options to employees when the vesting of such options is contingent upon performance milestones or the occurrence of an IPO or exit event.

December 4, 2018

US Court Allows Company to Cancel a Transaction Based on “Material Adverse Effect” Clause in Agreement

The Delaware Court of Chancery issued a precedent recently, whereby an acquisition agreement may be cancelled due to the occurrence of a “Material Adverse Effect” (MAE) in the acquired entity.

November 27, 2018

A Workshop: Legal Primer for US Hedge Fund Investing

Barnea and Friedman Kaplan hosted today a workshop for participants from the Israel Hedge Funds Association. Dr. Zvi Gabbay gave a lecture entitled "International Enforcement: Being in Israel Does Not Keep the SEC Away."

November 20, 2018

Barnea represented Senetas Corporation Ltd.

Our firm represented Senetas Corporation in a USD 8 million investment in the Israeli cyber company Votiro Cybersec Global Limited

November 15, 2018

How to Negotiate with a Prospective Angel Investor

How you negotiate with an angel investor goes a long way in determining whether you will receive funding or not. Click to read some top tips for negotiating with a potential angel investor.

November 8, 2018

Barnea Represented Sakal Global Duty Free Ltd.

Our firm represented the owner of Sakal Global Duty Free Ltd. in the sale of the company as part of the sale of the entire Sakal Group to businessman Teddy Sagi.

November 6, 2018

Israel Innovation Tour: UK Delegation

Our firm hosted today a delegation of senior executives from British companies and authorities. The delegation is part of a cooperation with the consulting company Ntegra, Bird and Bird law firm and Barnea. As part of the tour, the delegation visited our firm and met several startups for potential investment. Micky Barnea also provided a case study of the activity of foreign companies in Israel.

November 6, 2018

The People Who Shake Management: 70% on Mellanox

Micky Barnea and Adv. Steve Wolosky are featured in a TheMarker profile about being the representatives of the American investment fund Starboard Value during its investment in Mellanox.